Gene · 4627
Papers4,242
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
241 to 260 of 4,242
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Genomic insights into mRNA COVID-19 vaccines efficacy: Linking genetic polymorphisms to waning immunity. | Hum Vaccin Immunother | 2024 | 39254005 | PubTator, text mining | PubMed |
| [Developments of high-throughput sequencing-based diagnosis of congenital thrombocytopenia/platelet disorders in a registry study]. | Rinsho Ketsueki | 2024 | 39231703 | PubTator, text mining | PubMed |
| Exploring the Genotype-Phenotype Correlations in a Child with Inherited Seizure and Thrombocytopenia by Digenic Network Analysis. | Genes (Basel) | 2024 | 39202364 | PubTator, text mining | PubMed |
| Testing Reported Associations of Gene Variants with Non-Syndromic Orofacial Clefts in the Polish Population. | Biomedicines | 2024 | 39200165 | PubTator, text mining | PubMed |
| Unveiling the enigmatic role of MYH9 in tumor biology: a comprehensive review. | Cell Commun Signal | 2024 | 39192336 | PubTator, text mining | PubMed |
| YAP1 regulates thrombopoiesis by binding to MYH9 in immune thrombocytopenia. | Blood | 2024 | 39190466 | PubTator, text mining | PubMed |
| The Potential of Eight Plasma Proteins as Biomarkers in Redefining Leptospirosis Diagnosis. | J Proteome Res | 2024 | 39150348 | PubTator, text mining | PubMed |
| Exploring the nexus between MYH9 and tumors: novel insights and new therapeutic opportunities. | Front Cell Dev Biol | 2024 | 39149512 | PubTator, text mining | PubMed |
| Disulfidptosis-related gene expression reflects the prognosis of drug-resistant cancer patients and inhibition of MYH9 reverses sorafenib resistance. | Transl Oncol | 2024 | 39146597 | PubTator, text mining | PubMed |
| The Aryl Hydrocarbon Receptor Regulates Invasiveness and Motility in Acute Myeloid Leukemia Cells through Expressional Regulation of Non-Muscle Myosin Heavy Chain IIA. | Int J Mol Sci | 2024 | 39125717 | PubTator, text mining | PubMed |
| TMEFF1 is a neuron-specific restriction factor for herpes simplex virus. | Nature | 2024 | 39048823 | Swiss-Prot, curated | PubMed |
| Macrothrombocytopenia with leukocyte inclusions in a patient with Wilson disease: a case report and literature review. | BMC Med Genomics | 2024 | 39020387 | PubTator, text mining | PubMed |
| Membrane-bound Heat Shock Protein mHsp70 Is Required for Migration and Invasion of Brain Tumors. | Cancer Res Commun | 2024 | 39015084 | PubTator, text mining | PubMed |
| Isotoosendanin inhibits triple-negative breast cancer metastasis by reducing mitochondrial fission and lamellipodia formation regulated by the Smad2/3-GOT2-MYH9 signaling axis. | Acta Pharmacol Sin | 2024 | 39009651 | PubTator, text mining | PubMed |
| Disulfidptosis: A Novel Prognostic Criterion and Potential Treatment Strategy for Diffuse Large B-Cell Lymphoma (DLBCL). | Int J Mol Sci | 2024 | 39000261 | PubTator, text mining | PubMed |
| SFN promotes renal fibrosis via binding with MYH9 in chronic kidney disease. | Eur J Pharmacol | 2024 | 38986830 | PubTator, text mining | PubMed |
| Melatonin-loaded mesoporous zinc- and gallium-doped hydroxyapatite nanoparticles to control infection and bone repair. | Biomater Sci | 2024 | 38980095 | PubTator, text mining | PubMed |
| Mapping the IMiD-dependent cereblon interactome using BioID-proximity labelling. | FEBS J | 2024 | 38975872 | PubTator, text mining | PubMed |
| Identification of a novel MYH9-related disease-associated mutation with multiple faintly staining Döhle-like bodies. | Pediatr Blood Cancer | 2024 | 38965687 | PubTator, text mining | PubMed |
| Aberrant proximal tubule DNA methylation underlies phenotypic changes related to kidney dysfunction in patients with diabetes. | Am J Physiol Renal Physiol | 2024 | 38961842 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4627/papers?page=13